McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, MacIntyre I, Maseri A
Circulation. 1986 Dec;74(6):1243-7. doi: 10.1161/01.cir.74.6.1243.
To investigate the action of calcitonin gene-related peptide (CGRP) on human epicardial coronary arteries, six patients received intracoronary CGRP at doses of 50,100, and 200 ng/min. The effect of CGRP was measured angiographically with a computerized analysis system. A dose-dependent increase in coronary arterial diameter was observed. At the highest dose there were 34%, 7%, 38%, and 40% mean increases in the diameters of the circumflex, proximal, mid, and distal left anterior descending arteries, respectively. No further increase in diameter was found after a subsequent dose of 1 mg intracoronary isosorbide dinitrate. Prior infusion of CGRP did not prevent coronary arterial spasm induced by ergonovine in two patients with variant angina, but a subsequent bolus of CGRP partially relieved the spasm. We propose that CGRP has a role in the regulation of coronary vascular smooth muscle tone.
为研究降钙素基因相关肽(CGRP)对人冠状动脉的作用,6例患者接受了剂量分别为50、100和200 ng/min的冠状动脉内CGRP注射。采用计算机分析系统通过血管造影术测量CGRP的作用。观察到冠状动脉直径呈剂量依赖性增加。在最高剂量时,左旋支、左前降支近端、中段和远端动脉直径平均分别增加34%、7%、38%和40%。冠状动脉内随后注射1 mg硝酸异山梨酯后,直径未进一步增加。在2例变异型心绞痛患者中,预先输注CGRP未能预防麦角新碱诱发的冠状动脉痉挛,但随后推注CGRP可部分缓解痉挛。我们认为CGRP在冠状动脉血管平滑肌张力调节中起作用。